Scarica l'app Stockscreener
6.5979
6.37%
-0.3921
Precedente Chiudi:
$6.99
Aprire:
$6.95
Volume 24 ore:
80,790
Relative Volume:
0.20
Capitalizzazione di mercato:
$436.07M
Reddito:
$198.53M
Utile/perdita netta:
$-63.68M
Rapporto P/E:
-6.4546
EPS:
-1.0222
Flusso di cassa netto:
$-41.50M
1 W Prestazione:
-15.55%
1M Prestazione:
-21.05%
6M Prestazione:
+24.43%
1 anno Prestazione:
-48.14%
Intervallo 1D:
$6.53
$7.09
Intervallo di 1 settimana:
$6.53
$8.1299
Portata 52W:
$3.92
$12.62
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Nome
Treace Medical Concepts Inc
Settore
Industria
Telefono
(904) 373-5940
Indirizzo
100 PALMETTO PARK PLACE, PONTE VEDRA
Confronta TMCI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
6.60 | 436.07M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
125.31 | 215.93B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
92.25 | 138.09B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
341.92 | 132.98B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
81.46 | 104.78B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.91 | 39.98B | 5.72B | 4.17B | 259.90M | 6.97 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-04 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-12-31 | Iniziato | Lake Street | Buy |
| 2024-12-17 | Ripresa | JP Morgan | Neutral |
| 2024-05-16 | Downgrade | UBS | Buy → Neutral |
| 2024-05-08 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-05-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-05-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | Downgrade | Stifel | Buy → Hold |
| 2024-05-08 | Downgrade | Truist | Buy → Hold |
| 2023-09-29 | Iniziato | UBS | Buy |
| 2023-05-01 | Iniziato | Truist | Buy |
| 2023-04-11 | Iniziato | Stephens | Equal-Weight |
| 2022-05-12 | Iniziato | BTIG Research | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | Iniziato | JP Morgan | Overweight |
| 2021-05-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-05-18 | Iniziato | SVB Leerink | Outperform |
| 2021-05-18 | Iniziato | Stifel | Buy |
Mostra tutto
Treace Medical Concepts Inc Borsa (TMCI) Ultime notizie
Truist Cuts Price Target on Treace Medical Concepts to $8 From $9.50, Keeps Hold Rating - MarketScreener
Raymond James Financial Inc. Makes New Investment in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Treace Medical Concepts Insiders Up US$3.0m On US$7.83m Investment - simplywall.st
52,742 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Acquired by Raymond James Financial Inc. - Defense World
Treace Medical Concepts names John Treace as chair - MSN
Treace Medical Concepts: No Solid Footing (NASDAQ:TMCI) - Seeking Alpha
Treace Medical appoints John Treace as chairman of the board - MSN
Treace Medical Concepts Names John Treace as Chairman - MarketScreener
Treace Announces Upcoming Board Chair Transition - MarketScreener
Treace Medical Concepts CEO to Become Board Chairman - TipRanks
Form DEF 14A TREACE MEDICAL CONCEPTS, For: Apr 07 - StreetInsider
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Sees Significant Decrease in Short Interest - MarketBeat
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Short Interest Down 17.9% in March - Defense World
Quantbot Technologies LP Buys Shares of 9,336 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.14 Consensus Target Price from Brokerages - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.14 Average PT from Analysts - Defense World
Charles Schwab Investment Management Inc. Sells 41,523 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference - The Manila Times
Treace Medical Concepts Studies of Procedures to Treat Mid-Foot Deformities Show Positive Results - Marketscreener.com
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
Breakthrough Clinical Results: Treace Bunion Surgery Achieves Near-Perfect Success Rate - Stock Titan
45,923 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Bought by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Bank of New York Mellon Corp Has $937,000 Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference - TradingView
Revolutionary Bunion Treatment: Treace Launches 4 New Minimally Invasive Systems - Stock Titan
45,923 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Purchased by Connor Clark & Lunn Investment Management Ltd. - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Insider Sean F. Scanlan Sells 50,000 Shares - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Trading 4.7% HigherShould You Buy? - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Sees Large Increase in Short Interest - MarketBeat
William Blair Investment Management LLC Raises Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Treace Medical Concepts chief innovation officer sells $398k in stock - Investing.com UK
Treace Medical Concepts (NASDAQ:TMCI) Price Target Lowered to $9.50 at Truist Financial - MarketBeat
Truist Financial Issues Pessimistic Forecast for Treace Medical Concepts (NASDAQ:TMCI) Stock Price - The AM Reporter
Truist Financial Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $9.50 - Defense World
Truist Financial Sticks to Its Hold Rating for Treace Medical Concepts (TMCI) - The Globe and Mail
Treace Medical Concepts (NASDAQ:TMCI) Shares Gap UpStill a Buy? - MarketBeat
John Treace Spends US$524k On Treace Medical Concepts Stock - Yahoo
Treace Medical Concepts Inc Azioni (TMCI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.50%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):